Okoshi Kouta, Sakurai Kenichi, Yamamoto Midori, Mori Chisato
Department of Sustainable Health Science, Graduate School of Medical and Pharmaceutical Sciences, Chiba University, Chiba, Japan.
Innovation Center, Central Research Laboratory, NIPPN Corporation, Kanagawa, Japan.
J Allergy Clin Immunol Glob. 2023 Jul 6;2(4):100137. doi: 10.1016/j.jacig.2023.100137. eCollection 2023 Nov.
The association of maternal antibiotic exposure during pregnancy with childhood allergic diseases remains unclear.
We aimed to evaluate the association of maternal exposure to antibiotic use during pregnancy with childhood allergic diseases up to the age of 3 years by using data from a large Japanese birth cohort.
We analyzed data on 78,678 pregnant women and their offspring aged 0 to 3 years. Prenatal antibiotic exposure was defined as the use of any antimicrobial agent during pregnancy. Information was collected from maternal interviews and medical record transcripts. The outcome variables in this study included preschool asthma, wheezing, food allergy, atopic dermatitis, eczema, allergic rhinoconjunctivitis, and any allergic disease. We used logistic regression analysis to evaluate the association of antibiotic exposure during pregnancy with childhood allergic diseases.
Among the participating mothers, 28.5% used antibiotics during pregnancy. Antibiotic exposure during pregnancy was associated with preschool asthma (adjusted odds ratio [aOR] = 1.12 [95% CI = 1.06-1.19]), wheezing (aOR = 1.11 [95% CI = 1.07-1.15]), allergic rhinoconjunctivitis (aOR = 1.10 [95% CI = 1.03-1.17]) and any allergic disease (aOR = 1.09 [95% CI = 1.05-1.14]) in offspring up to age 3 years. In contrast, maternal antibiotic use was not associated with food allergies, atopic dermatitis, or eczema. Additionally, the significant associations were not influenced by the timing of antibiotic exposure, sex of the infants, or maternal history of allergies.
Maternal antibiotic exposure during pregnancy is associated with an increased risk of childhood respiratory allergies.
孕期母亲使用抗生素与儿童过敏性疾病之间的关联尚不清楚。
我们旨在利用日本一个大型出生队列的数据,评估孕期母亲接触抗生素与3岁以下儿童过敏性疾病之间的关联。
我们分析了78678名孕妇及其0至3岁后代的数据。产前抗生素暴露定义为孕期使用任何抗菌药物。信息通过母亲访谈和病历记录收集。本研究的结局变量包括学龄前哮喘、喘息、食物过敏、特应性皮炎、湿疹、过敏性鼻结膜炎以及任何过敏性疾病。我们使用逻辑回归分析来评估孕期抗生素暴露与儿童过敏性疾病之间的关联。
在参与研究的母亲中,28.5%在孕期使用了抗生素。孕期抗生素暴露与3岁以下后代的学龄前哮喘(调整优势比[aOR]=1.12[95%置信区间(CI)=1.06 - 1.19])、喘息(aOR = 1.11[95% CI = 1.07 - 1.15])、过敏性鼻结膜炎(aOR = 1.10[95% CI = 1.03 - 1.17])以及任何过敏性疾病(aOR = 1.09[95% CI = 1.05 - 1.14])相关。相比之下,母亲使用抗生素与食物过敏、特应性皮炎或湿疹无关。此外,这些显著关联不受抗生素暴露时间、婴儿性别或母亲过敏史的影响。
孕期母亲接触抗生素与儿童呼吸道过敏风险增加有关。